Biological Effects of LEO 43204 in Actinic Keratosis

NCT02600598 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: LEO 43204 Gel, 0.037%
DRUG: LEO 43204 Gel, 0.037%

Sponsor

LEO Pharma